US Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-09-11
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-callable
US Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-09-11: 10Y at 5.70%, fitted curve 1M–40Y (4.42%–6.15%), 872 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 4.42% | — |
| 3M | 4.46% | 4.48% |
| 6M | 4.56% | 4.76% |
| 9M | 4.68% | 5.12% |
| 12M | 4.80% | 5.12% |
| 18M | 4.95% | 5.33% |
| 2Y | 5.03% | 5.35% |
| 3Y | 5.16% | 5.50% |
| 4Y | 5.27% | 5.74% |
| 5Y | 5.38% | 5.96% |
| 6Y | 5.47% | 6.13% |
| 7Y | 5.55% | 6.24% |
| 8Y | 5.61% | 6.25% |
| 9Y | 5.66% | 6.21% |
| 10Y | 5.70% | 6.25% |
| 15Y | 5.98% | 7.06% |
| 20Y | 6.09% | 6.83% |
| 25Y | 6.13% | 6.60% |
| 30Y | 6.15% | 6.47% |
| 40Y | 6.15% | 6.35% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 5.03% and the 10-year 5.70%, a 10Y−2Y spread of +66 bp — positively sloped — as of 2026-09-11. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-09-11 | 1m ago2026-08-12 | 2m ago2026-07-13 | 3m ago2026-06-12 | 4m ago2026-05-14 | 5m ago2026-04-14 | 6m ago2026-03-16 |
|---|---|---|---|---|---|---|---|
| 2Y | 5.03% | 4.69% | 4.63% | 4.57% | 4.48% | 4.37% | 4.14% |
| 10Y | 5.70% | 5.50% | 5.30% | 5.28% | 5.19% | 5.17% | 5.03% |
| 10Y − 2Y | +66 bp | +81 bp | +67 bp | +71 bp | +72 bp | +80 bp | +89 bp |
Yields by rating group
The same curve split by credit quality: 944 rated bonds across 3 rating bands, all maturities pooled. Median yield by band: AAA to AA- 5.36%, A+ to BBB- 5.60%, Speculative 6.65%.
Bonds in this curve
A selection of 30 of the 948 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Shire Acquisitions Investments Ireland DAC | 6.34% | 2026-09-23 | 3.20% | US82481LAD10 |
| Teva Pharmaceutical Industries LTD | 8.14% | 2026-10-01 | 3.15% | US88167AAE10 |
| Cardinal Health INC | 4.29% | 2026-11-15 | 4.70% | US14149YBQ08 |
| Abbvie INC | 3.88% | 2026-11-21 | 2.95% | US00287YBV02 |
| Roche Holding AG | 4.76% | 2027-01-28 | 2.38% | USU75000BL90 |
| Bausch Health Companies INC | 9.64% | 2027-01-31 | 8.50% | USU9098VAP77 |
| Teva Pharmaceutical Industries LTD | 5.18% | 2027-05-09 | 4.75% | US88167AAP66 |
| ELI Lilly & CO | 4.47% | 2027-05-15 | 3.10% | US532457BP26 |
| ELI Lilly & CO | 4.49% | 2027-08-14 | 4.15% | US532457CP17 |
| CVS Health Corp | 4.77% | 2027-08-21 | 1.30% | US126650DM98 |
| Cencora INC | 5.08% | 2027-12-15 | 3.45% | US03073EAP07 |
| Cencora INC | 5.14% | 2027-12-15 | 4.62% | US03073EAV74 |
| Edwards Lifesciences Corp | 5.15% | 2028-06-15 | 4.30% | US28176EAD04 |
| Sanofi SA | 4.84% | 2028-06-19 | 3.62% | US801060AD60 |
| Abbvie INC | 5.13% | 2029-03-15 | 4.80% | US00287YDS54 |
| ELI Lilly & CO | 4.95% | 2029-03-15 | 3.38% | US532457BV93 |
| Abbvie INC | 5.14% | 2030-03-15 | 4.88% | US00287YDZ97 |
| Abbvie INC | 5.18% | 2030-03-15 | 4.65% | US00287YEM75 |
| Abbott Laboratories | 5.17% | 2031-03-15 | 4.00% | US002824BS80 |
| Abbvie INC | 5.23% | 2031-03-15 | 4.95% | US00287YDT38 |
| BIO-RAD Laboratories INC | 5.68% | 2032-03-15 | 3.70% | US090572AQ17 |
| Abbott Laboratories | 5.38% | 2033-03-15 | 4.30% | US002824BT63 |
| Abbvie INC | 5.48% | 2034-03-15 | 5.05% | US00287YDU01 |
| Abbvie INC | 5.56% | 2035-03-15 | 5.20% | US00287YEA38 |
| Abbott Laboratories | 5.59% | 2036-03-15 | 4.65% | US002824BU37 |
| ELI Lilly & CO | 5.89% | 2039-03-15 | 3.88% | US532457BS64 |
| Abbvie INC | 6.07% | 2044-03-15 | 5.35% | US00287YDV83 |
| ELI Lilly & CO | 6.01% | 2049-03-15 | 3.95% | US532457BT48 |
| Abbvie INC | 6.13% | 2054-03-15 | 5.40% | US00287YDW66 |
| Merck & CO INC | 6.19% | 2061-12-10 | 2.90% | US58933YBG98 |